148 related articles for article (PubMed ID: 1697615)
1. Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates.
Birmingham DJ; Hebert LA; Cosio FG; VanAman ME
J Lab Clin Med; 1990 Aug; 116(2):242-52. PubMed ID: 1697615
[TBL] [Abstract][Full Text] [Related]
2. Experimental immune complex-mediated glomerulonephritis in the nonhuman primate.
Hebert LA; Cosio FG; Birmingham DJ; Mahan JD; Sharma HM; Smead WL; Goel R
Kidney Int; 1991 Jan; 39(1):44-56. PubMed ID: 1825859
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis.
Hebert LA; Birmingham DJ; Mahan JD; Shen XP; McAllister C; Cosio FG; Dillon JJ
Kidney Int; 1994 Feb; 45(2):493-9. PubMed ID: 7513033
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates.
Cosio FG; Shen XP; Birmingham DJ; Van Aman M; Hebert LA
J Immunol; 1990 Dec; 145(12):4198-206. PubMed ID: 2147938
[TBL] [Abstract][Full Text] [Related]
5. Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate.
Mahan JD; Hebert LA; McAllister C; Birmingham DJ; Shen XP; Cosio FG; Brandt J
Kidney Int; 1993 Oct; 44(4):716-25. PubMed ID: 7505036
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
Edberg JC; Kimberly RP; Taylor RP
Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
[TBL] [Abstract][Full Text] [Related]
7. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
Reist CJ; Liang HY; Denny D; Martin EN; Scheld WM; Taylor RP
Eur J Immunol; 1994 Sep; 24(9):2018-25. PubMed ID: 8088321
[TBL] [Abstract][Full Text] [Related]
8. In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor.
Taylor RP; Reist CJ; Sutherland WM; Otto A; Labuguen RH; Wright EL
J Immunol; 1992 Apr; 148(8):2462-8. PubMed ID: 1373171
[TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
10. Effects of immune complex formation and complement activation on circulating platelets in the primate.
Birmingham DJ; Hebert LA; Shen XP; Higgins P; Yeh CG; Creasey AA
Clin Immunol; 1999 Apr; 91(1):99-105. PubMed ID: 10219260
[TBL] [Abstract][Full Text] [Related]
11. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
12. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
13. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
14. Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation.
Reist CJ; Combs MJ; Croft BY; Taylor RP
Eur J Immunol; 1993 Nov; 23(11):3021-7. PubMed ID: 8223879
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
16. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model.
Taylor RP; Sutherland WM; Martin EN; Ferguson PJ; Reinagel ML; Gilbert E; Lopez K; Incardona NL; Ochs HD
J Immunol; 1997 Jan; 158(2):842-50. PubMed ID: 8993002
[TBL] [Abstract][Full Text] [Related]
17. Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate.
Hebert LA; Birmingham DJ; Mahan JD; Cosio FG; Dillon JJ; Sedmak DD; Shen XP; McAllister C
Am J Kidney Dis; 1997 Aug; 30(2):243-52. PubMed ID: 9261036
[TBL] [Abstract][Full Text] [Related]
18. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
[TBL] [Abstract][Full Text] [Related]
19. Removal of glomerular immune complexes in passive serum sickness nephritis by treatment in vivo with proteolytic enzymes.
Nakazawa M; Emancipator SN; Lamm ME
Lab Invest; 1986 Nov; 55(5):551-6. PubMed ID: 2430139
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.
Beynon HL; Davies KA; Haskard DO; Walport MJ
J Immunol; 1994 Oct; 153(7):3160-7. PubMed ID: 8089493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
